Correlation Between Abivax SA and Transgene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abivax SA and Transgene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abivax SA and Transgene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abivax SA and Transgene SA, you can compare the effects of market volatilities on Abivax SA and Transgene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abivax SA with a short position of Transgene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abivax SA and Transgene.

Diversification Opportunities for Abivax SA and Transgene

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Abivax and Transgene is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Abivax SA and Transgene SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transgene SA and Abivax SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abivax SA are associated (or correlated) with Transgene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transgene SA has no effect on the direction of Abivax SA i.e., Abivax SA and Transgene go up and down completely randomly.

Pair Corralation between Abivax SA and Transgene

Assuming the 90 days trading horizon Abivax SA is expected to under-perform the Transgene. But the stock apears to be less risky and, when comparing its historical volatility, Abivax SA is 1.38 times less risky than Transgene. The stock trades about -0.35 of its potential returns per unit of risk. The Transgene SA is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  68.00  in Transgene SA on November 7, 2024 and sell it today you would earn a total of  1.00  from holding Transgene SA or generate 1.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy91.3%
ValuesDaily Returns

Abivax SA  vs.  Transgene SA

 Performance 
       Timeline  
Abivax SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abivax SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Transgene SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Transgene SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Abivax SA and Transgene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abivax SA and Transgene

The main advantage of trading using opposite Abivax SA and Transgene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abivax SA position performs unexpectedly, Transgene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transgene will offset losses from the drop in Transgene's long position.
The idea behind Abivax SA and Transgene SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio